XML 15 R4.htm IDEA: XBRL DOCUMENT v3.5.0.2
Consolidated Statements of Operations (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2016
Sep. 30, 2015
Sep. 30, 2016
Sep. 30, 2015
Income Statement [Abstract]        
Net sales $ 1,279,028 $ 1,188,037 $ 3,340,276 $ 3,476,570
Cost of sales 1,076,895 876,761 2,641,192 2,527,567
Gross profit 202,133 311,276 699,084 949,003
Selling, general and administrative expenses 72,729 57,248 179,757 170,321
Transaction and integration-related costs 82,841 0 90,550 0
Income from operations 46,563 254,028 428,777 778,682
Other income (expense)        
Interest expense (24,366) (8,211) (36,966) (26,760)
Other income, net 41,265 2,636 52,091 33,790
Income before income taxes 63,462 248,453 443,902 785,712
(Benefit from) provision for income taxes (6,552) 60,033 129,332 236,824
Net income 70,014 188,420 314,570 548,888
Net income attributable to noncontrolling interests 4,352 4,816 14,656 13,847
Net income attributable to Westlake Chemical Corporation $ 65,662 $ 183,604 $ 299,914 $ 535,041
Earnings per common share attributable to Westlake Chemical Corporation:        
Basic (usd per share) $ 0.51 $ 1.39 $ 2.31 $ 4.04
Diluted (usd per share) $ 0.51 $ 1.39 $ 2.29 $ 4.02
Weighted average common shares outstanding:        
Basic (in shares) 128,793,661 131,664,296 129,519,577 132,301,814
Diluted (in shares) 129,379,956 132,121,235 130,103,897 132,786,534
Dividends per common share (usd per share) $ 0.1906 $ 0.1815 $ 0.5536 $ 0.5115